An MRI technique called quantitative susceptibility mapping (QSM) can be used to accurately identify remyelinated brain lesions in people with…
Articles by Marisa Wexler, MS
The safety and efficacy of the approved multiple sclerosis (MS)Â therapy Mavenclad (cladribine) in a real-world group…
Long-term treatment with Zeposia (ozanimod) stabilizes or even improves cognitive function in adults with relapsing forms of multiple…
People with relapsing forms of multiple sclerosis (MS) who were continuously on Kesimpta (ofatumumab) for up to four…
Proteins called tenascins block the regeneration of myelin by modulating the activity of oligodendrocytes, myelin-making cells of the central nervous…
Unusual growth in an immune cell class called myeloid cells is evident in the bone marrow of people with multiple sclerosis…
Cionic‘s leg-worn Neural Sleeve, recently authorized in the U.S. to aid walking in people with multiple sclerosis (MS)…
Treatment with the experimental immune-modulating therapy vidofludimus calcium reduced disease activity on MRI scans in adults with relapsing-remitting multiple…
Treatment with foralumab nasal spray resulted in marked clinical improvements after three months in the second secondary progressive multiple…
The overall risk of death is about 75% higher for people with multiple sclerosis (MS) than in the general…
A medication currently approved to treat certain kinds of cancer, called topotecan, could be repurposed for treating neuroinflammatory conditions such…
More than half of the people with multiple sclerosis (MS) treated with Aubagio (teriflunomide) showed no evidence of disease…
The U.S. Food and Drug Administration (FDA) is extending by three months its review of ublituximab, an experimental anti-CD20 antibody…
A new scoring system might more precisely evaluate disease development, severity, and treatment response in a commonly used mouse model…
Among multiple sclerosis (MS) patients starting on Lemtrada (alemtuzumab), an early decrease in the leakiness of the blood-brain…
Treatment with Ponvory (ponesimod) significantly reduces the risk of worsening disability or new relapses for people with relapsing forms…
People with multiple sclerosis (MS) are more likely to have lesions in three regions of the brain — the…
ABX-002, an experimental treatment for multiple sclerosis (MS) being developed by Autobahn Therapeutics, promoted the restoration of the…
Among people with relapsing-remitting multiple sclerosis (RRMS), those who are married and have more formal education are more likely…
Many people newly diagnosed with relapsing-remitting multiple sclerosis (RRMS) experience substantial “hidden disabilities,” such as depression or fatigue, a study…
Among multiple sclerosis (MS) patients on rituximab, higher B-cell counts are predictive of a better antibody-based response to a…
The experimental therapy XPro1595 was found to promote remyelination — the repair of the myelin sheath — in a mouse…
Eating a ketogenic diet — one low in carbohydrates and high in fats — led to markedly less fatigue and…
Researchers have identified four new brain proteins that are targeted by inflammatory T-cells in multiple sclerosis (MS), which could…
More than half of Canadians with multiple sclerosis (MS) report using cannabis to help manage their symptoms, according to…
Tysabri (natalizumab) given every six weeks was found to be similarly effective as the standard four-week dosing schedule at…
The National Institute for Health and Care Evidence (NICE) in England has issued a briefing on the use of Icometrix‘s…
Long-term treatment with tolebrutinib significantly reduced signs of disease-related brain damage in people with relapsing multiple sclerosis (MS),…
Children with multiple sclerosis (MS) who in their first year after disease onset experience pyramidal symptoms, such as spasticity…
The first participant has been enrolled in a new clinical trial that is testing whether an antihistamine in combination with…